The clinical and preclinical studies mainly involved the analysis of PRMT5-ISO5 levels responded to radiation, the effects of increased PRMT-ISO5 and PRMT5 deficiency on xenograft tumor and primary HCC, by establishing xenograft tumor models, and liver-specific Prmt5 knockout spontaneous HCC mice. Here, PRMT5 is linked to hepatocellular carcinoma.